The manufacturer ITC has determined that some citrate activated partial thromboplastin time (APTT) cuvettes may recover higher than expected results in normal individuals. Investigation into the affected lot identified that when performing tests on non-heparinized, e.g., normal blood samples, results may average higher than historic values. Test results performed on patients receiving heparin therapy are not affected.